Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Actas Urologicas Espanolas
|
October 21, 2022
Hormone sensitive protocol for metastatic prostate cancer, an update
J L Álvarez Ossorio, M Rodrigo Aliaga, A Rodríguez Antolin, et al.
Actas Urologicas Espanolas
|
March 14, 2017
Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study - GESCAP group
F Gómez-Veiga, A Rodríguez-Antolín, B Miñana, et al.
Actas Urologicas Espanolas
|
March 20, 2022
Non-metastatic castration-resistant prostate cancer: management recommendations
A Alcaraz Asensio, J L Alvarez Ossorio, J M Cozar Olmo, et al.
Actas Urologicas Espanolas
|
January 4, 2018
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice
M Unda-Urzaiz, J M Cozar-Olmos, B Miñana-Lopez, et al.
Actas Urologicas Espanolas
|
July 1, 1997
[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections]
J M Martínez Jabaloyas, S Sanz Chinesta, J F Jiménez Cruz, et al.
Actas Urologicas Espanolas
|
May 28, 2013
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of Urology
H Villavicencio, C Hernández, A Gómez, et al.
British Journal of Cancer
|
June 27, 2013
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
A Alcaraz, R González-López, J Morote, et al.
The Journal of Urology
|
September 3, 2013
Bladder cancer in Spain 2011: population based study
B Miñana, J M Cózar, J Palou, et al.
British Journal of Cancer
|
June 1, 2013
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
C de la Piedra, A Alcaraz, J Bellmunt, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Actas Urologicas Espanolas
|
October 21, 2022
Hormone sensitive protocol for metastatic prostate cancer, an update
J L Álvarez Ossorio, M Rodrigo Aliaga, A Rodríguez Antolin, et al.
Actas Urologicas Espanolas
|
March 14, 2017
Diagnosis and treatment for clinically localized prostate cancer. Adherence to the European Association of Urology clinical guidelines in a nationwide population-based study - GESCAP group
F Gómez-Veiga, A Rodríguez-Antolín, B Miñana, et al.
Actas Urologicas Espanolas
|
March 20, 2022
Non-metastatic castration-resistant prostate cancer: management recommendations
A Alcaraz Asensio, J L Alvarez Ossorio, J M Cozar Olmo, et al.
Actas Urologicas Espanolas
|
January 4, 2018
Safety and efficacy of various strains of bacille Calmette-Guérin in the treatment of bladder tumours in standard clinical practice
M Unda-Urzaiz, J M Cozar-Olmos, B Miñana-Lopez, et al.
Actas Urologicas Espanolas
|
July 1, 1997
[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections]
J M Martínez Jabaloyas, S Sanz Chinesta, J F Jiménez Cruz, et al.
Actas Urologicas Espanolas
|
May 28, 2013
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of Urology
H Villavicencio, C Hernández, A Gómez, et al.
British Journal of Cancer
|
June 27, 2013
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
A Alcaraz, R González-López, J Morote, et al.
The Journal of Urology
|
September 3, 2013
Bladder cancer in Spain 2011: population based study
B Miñana, J M Cózar, J Palou, et al.
British Journal of Cancer
|
June 1, 2013
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
C de la Piedra, A Alcaraz, J Bellmunt, et al.
Page
of 8